However, in PC, more often than not, increased ELAVL1 concentrations in the cell cytoplasm are considered a positive sign, not only in terms of response to gemcitabine but also in overall patient survival [10,13,14,51]. Here, ELAVL1 is linked to pachyonychia congenita.